Healthcare News and Research

Latest Healthcare News and Research

Non-invasive diagnostic imaging can rule out CAD in about 50% of women with atypical chest pain

Non-invasive diagnostic imaging can rule out coronary artery disease (CAD) in about 50% of women with atypical chest pain who are at relatively low risk for CAD, while exposing them to only a modest dose of radiation.

13 Aug 2015

Common marker can help identify patients at high risk for deadly cardiac events

A marker commonly used to determine if a patient is having a heart attack can also be used to identify stable patients at high risk for deadly cardiac events, according to a new study led by investigators at Brigham and Women's Hospital.

13 Aug 2015

Echo's non-invasive CGM system to be designated as Class 2 medical device in China

Echo Therapeutics, Inc., a medical device company focused on non-invasive continuous glucose monitoring (CGM) and associated technologies, today announced that, after numerous consultations with the Chinese government, its strategic partner, Medical Technologies Innovation Asia, Ltd., believes that Echo's locally produced needle-free CGM products will be designated as a Class 2 medical device.

12 Aug 2015

Lucideon acquires second Dynamic Secondary Ion Mass Spectrometer

Lucideon is pleased to announce the acquisition of a second Dynamic Secondary Ion Mass Spectrometer (DSIMS). The investment doubles the capacity for DSIMS analysis at Lucideon and represents a response to the demand for the service and Lucideon’s commitment to satisfying customer requirements.

From Lucideon 12 Aug 2015

Dimension Data ranked 57th on 2015 Healthcare Informatics 100 list

Dimension Data, the $6.7 billion global ICT solutions and services provider, today announced that it ranked 57th on the 2015 Healthcare Informatics (HCI) 100 list. This year's ranking marks the third year in row Dimension Data has been included on the list.

12 Aug 2015

Imprimis, Advanced Dosage sign license agreement for proprietary compounded ophthalmic formulations

Imprimis Pharmaceuticals, Inc., a pharmaceutical company focused on the development and commercialization of proprietary compounded drug formulations, today announced that it has entered into a license agreement with Advanced Dosage Forms, Inc. to expand Imprimis' proprietary ophthalmic injectable and combination topical compounded formulations into Canada. Under the agreement, the licensee has the rights to formulate, market and sell these formulations across Canada.

12 Aug 2015

New Frost & Sullivan analysis finds that wearable devices to play large role in healthcare industry

The fledgling wearable devices market currently caters to a niche customer base. Improvements in devices and newer, interesting use cases will accelerate the transition to mass market proliferation. In addition to popular device manufacturers showcasing their wearable device ventures, an increasing number of industry-specific original equipment manufacturers are entering the market in partnership with technology companies.

12 Aug 2015

NEHEN selects Cognizant and TriZetto to manage technology infrastructure, improve efficiency and patient care

Cognizant today announced that the New England Healthcare Exchange Network, a consortium of regional payers and providers in the Northeast U.S., has selected Cognizant and its subsidiary TriZetto to digitally transform and manage its technology infrastructure to foster seamless collaboration across member organizations, optimize costs, and improve efficiency and patient care.

12 Aug 2015

Concord Medical closes acquisition of additional ownership interest in MD Anderson Proton Therapy Center

Concord Medical Services Holdings Limited, a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that it has closed the acquisition of additional ownership interest of The University of Texas MD Anderson Cancer Center Proton Therapy Center ("MD Anderson Proton Therapy Center").

12 Aug 2015

Janssen signs license agreement with Alligator Bioscience for immuno-oncology antibody

Janssen Biotech, Inc., one of the Janssen pharmaceutical companies of Johnson & Johnson announced today an exclusive, worldwide license agreement with Alligator Bioscience AB for ADC-1013, an immuno-oncology agent currently in Phase 1 clinical studies.

12 Aug 2015

Scientists identify molecular pathway that can contribute to vision loss in macular degeneration

Scientists have identified a pathway that leads to the formation of atypical blood vessels that can cause blindness in people with age-related macular degeneration.

12 Aug 2015

TEAAM trial finds that testosterone has no effect on atherosclerosis progression

Testosterone sales have grown rapidly over the last decade, but few studies have examined the long-term effects of taking testosterone on cardiovascular health and other important outcomes. This week, investigators from Brigham and Women's Hospital report the results of the Testosterone's Effects on Atherosclerosis Progression in Aging Men (TEAAM) trial in the Journal of the American Medical Association.

12 Aug 2015

New Johns Hopkins study shows hepatitis C infection may spell heart trouble

People infected with the hepatitis C virus are at risk for liver damage, but the results of a new Johns Hopkins study now show the infection may also spell heart trouble.

12 Aug 2015

Researchers describe new Lab-on-a-Disc device for fast and reliable diagnostics of urinary tract infections

Urinary tract infections can quickly move from being a merely miserable experience to a life-threatening condition. Untreated cases may trigger sepsis, which occurs when the immune system, in an attempt to fight off the infection, inadvertently activates body-wide inflammation that can cause blood clots and leaky blood vessels.

12 Aug 2015

Cycle Technologies launches new period-tracking and fertility app

Cycle Technologies today announced the launch of Dot, a period-tracking and fertility app based on the patent-pending Dynamic Optimal Timing (DOT) approach. This new family planning method accurately determines a woman's risk of pregnancy for each day of her cycle using just her period start dates.

11 Aug 2015

Aeterna Zentaris reports that DSMB scheduled to close second interim analysis of ZoptEC Phase 3 trial in early October

Aeterna Zentaris Inc. today announced that the independent Data and Safety Monitoring Board for the pivotal Phase 3 ZoptEC (Zoptarelin Doxorubicin in Endometrial Cancer) study with zoptarelin doxorubicin in women with advanced, recurrent or metastatic endometrial cancer, will complete a pre-specified second interim efficacy and safety analysis of the compound in early October 2015.

11 Aug 2015

PHA announces keynote speakers for 16th annual Population Health Forum

The Population Health Alliance has just announced its keynote speakers for the organization's 16th annual Population Health Forum. This year's line-up includes noted journalist Eleanor Clift, political expert Mark Siegel, Director of Physician Regulatory issues for CMS Dr. William Rogers, and industry expert and Oliver Wyman Partner Sam Glick.

11 Aug 2015

Sexting, Internet safety climb higher on list of major health concerns for children

With more kids online and using cell phones at increasingly younger ages, two issues have quickly climbed higher on the public's list of major health concerns for children across the U.S: sexting and Internet safety.

11 Aug 2015

Johns Hopkins researchers identify best practices that give patients a positive hospital experience

Based on responses to questionnaires and letters sent to CEOs and medical personnel from a nationwide sample of 53 hospitals, Johns Hopkins investigators have identified a handful of best practices they say are most likely to give patients a positive hospital experience, a sense of satisfaction and the feeling they come first.

11 Aug 2015

FDA accepts sNDA to review Brintellix clinical trial data for treatment of major depressive disorder

Takeda Pharmaceutical Company Limited (Takeda) and H. Lundbeck A/S (Lundbeck) announced today the U.S. Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) for review to add clinical data regarding the effect of Brintellix (vortioxetine) on certain aspects of cognitive function in adults with Major Depressive Disorder (MDD) to the current product label.

11 Aug 2015

Healthcare News and Research

Latest Healthcare News and Research

Non-invasive diagnostic imaging can rule out CAD in about 50% of women with atypical chest pain

Common marker can help identify patients at high risk for deadly cardiac events

Echo's non-invasive CGM system to be designated as Class 2 medical device in China

Lucideon acquires second Dynamic Secondary Ion Mass Spectrometer

Dimension Data ranked 57th on 2015 Healthcare Informatics 100 list

Imprimis, Advanced Dosage sign license agreement for proprietary compounded ophthalmic formulations

New Frost & Sullivan analysis finds that wearable devices to play large role in healthcare industry

NEHEN selects Cognizant and TriZetto to manage technology infrastructure, improve efficiency and patient care

Concord Medical closes acquisition of additional ownership interest in MD Anderson Proton Therapy Center

Janssen signs license agreement with Alligator Bioscience for immuno-oncology antibody

Scientists identify molecular pathway that can contribute to vision loss in macular degeneration

TEAAM trial finds that testosterone has no effect on atherosclerosis progression

New Johns Hopkins study shows hepatitis C infection may spell heart trouble

Researchers describe new Lab-on-a-Disc device for fast and reliable diagnostics of urinary tract infections

Cycle Technologies launches new period-tracking and fertility app

Aeterna Zentaris reports that DSMB scheduled to close second interim analysis of ZoptEC Phase 3 trial in early October

PHA announces keynote speakers for 16th annual Population Health Forum

Sexting, Internet safety climb higher on list of major health concerns for children

Johns Hopkins researchers identify best practices that give patients a positive hospital experience

FDA accepts sNDA to review Brintellix clinical trial data for treatment of major depressive disorder

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Healthcare News and Research

Latest Healthcare News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in